Olivier Schwartz - Publications

Affiliations: 
Virology Institut Pasteur, Paris, Paris, France 

209 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Mahé D, Bourgeau S, da Silva J, Schlederer J, Satie AP, Kuassivi N, Mathieu R, Guillou YM, Le Tortorec A, Guivel-Benhassine F, Schwartz O, Plotton I, Dejucq-Rainsford N. SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects . Journal of Virology. e0110423. PMID 37830818 DOI: 10.1128/jvi.01104-23  0.381
2023 Lingas G, Planas D, Péré H, Porrot F, Guivel-Benhassine F, Staropoli I, Duffy D, Chapuis N, Gobeaux C, Veyer D, Delaugerre C, Le Goff J, Getten P, Hadjadj J, Bellino A, ... ... Schwartz O, et al. Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis. Clinical Pharmacology and Therapeutics. PMID 37795693 DOI: 10.1002/cpt.3069  0.307
2023 Vrignaud LL, Schwartz O, Bruel T. Polyfunctionality of broadly neutralizing HIV-1 antibodies. Current Opinion in Hiv and Aids. 18: 178-183. PMID 37249912 DOI: 10.1097/COH.0000000000000799  0.401
2023 Goldberg BS, Spencer DA, Pandey S, Ordonez T, Barnette P, Yu Y, Gao L, Dufloo J, Bruel T, Schwartz O, Ackerman ME, Hessell AJ. Complement contributes to antibody-mediated protection against repeated SHIV challenge. Proceedings of the National Academy of Sciences of the United States of America. 120: e2221247120. PMID 37155897 DOI: 10.1073/pnas.2221247120  0.315
2022 Aicher SM, Streicher F, Chazal M, Planas D, Luo D, Buchrieser J, Nemcova M, Seidlova V, Zukal J, Serra-Cobo J, Pontier D, Pain B, Zimmer G, Schwartz O, Roingeard P, et al. Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells. Journal of Virology. e0060822. PMID 35862713 DOI: 10.1128/jvi.00608-22  0.383
2022 Mac Kain A, Maarifi G, Aicher SM, Arhel N, Baidaliuk A, Munier S, Donati F, Vallet T, Tran QD, Hardy A, Chazal M, Porrot F, OhAinle M, Carlson-Stevermer J, Oki J, ... ... Schwartz O, et al. Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen. Nature Communications. 13: 2442. PMID 35508460 DOI: 10.1038/s41467-022-30134-9  0.329
2022 Molinos-Albert LM, Lorin V, Monceaux V, Orr S, Essat A, Dufloo J, Schwartz O, Rouzioux C, Meyer L, Hocqueloux L, Sáez-Cirión A, Mouquet H. Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers. Nature Communications. 13: 1944. PMID 35410989 DOI: 10.1038/s41467-022-29511-1  0.386
2022 Lorin V, Fernández I, Masse-Ranson G, Bouvin-Pley M, Molinos-Albert LM, Planchais C, Hieu T, Péhau-Arnaudet G, Hrebík D, Girelli-Zubani G, Fiquet O, Guivel-Benhassine F, Sanders RW, Walker BD, Schwartz O, et al. Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller. The Journal of Experimental Medicine. 219. PMID 35230385 DOI: 10.1084/jem.20212045  0.319
2022 Dufloo J, Planchais C, Frémont S, Lorin V, Guivel-Benhassine F, Stefic K, Casartelli N, Echard A, Roingeard P, Mouquet H, Schwartz O, Bruel T. Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells. Nature Communications. 13: 630. PMID 35110562 DOI: 10.1038/s41467-022-28307-7  0.445
2022 Claireaux M, Robinot R, Kervevan J, Patgaonkar M, Staropoli I, Brelot A, Nouël A, Gellenoncourt S, Tang X, Héry M, Volant S, Perthame E, Avettand-Fenoël V, Buchrieser J, Cokelaer T, ... ... Schwartz O, et al. Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry. Nature Communications. 13: 521. PMID 35082297 DOI: 10.1038/s41467-022-28130-0  0.454
2021 Goldberg BS, Kaku CI, Dufloo J, Bruel T, Schwartz O, Spencer DA, Hessell AJ, Ackerman ME. Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity. Mbio. 12: e0174321. PMID 34634936 DOI: 10.1128/mBio.01743-21  0.344
2021 Michael Rajah M, Bernier A, Buchrieser J, Schwartz O. The mechanism and consequences of SARS-CoV-2 spike-mediated fusion and syncytia formation. Journal of Molecular Biology. 167280. PMID 34606831 DOI: 10.1016/j.jmb.2021.167280  0.315
2021 Luo X, Mouquet H, Schwartz O, Greene WC. Bystander CD4 T-cell death is inhibited by broadly neutralizing anti-HIV antibodies only at levels blocking cell-to-cell viral transmission. The Journal of Biological Chemistry. 101098. PMID 34418431 DOI: 10.1016/j.jbc.2021.101098  0.466
2021 Martinat C, Cormier A, Tobaly-Tapiero J, Palmic N, Casartelli N, Mahboubi B, Coggins SA, Buchrieser J, Persaud M, Diaz-Griffero F, Espert L, Bossis G, Lesage P, Schwartz O, Kim B, et al. SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells. Nature Communications. 12: 4582. PMID 34321470 DOI: 10.1038/s41467-021-24802-5  0.338
2021 Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, Planchais C, Porrot F, Guivel-Benhassine F, Van der Werf S, Casartelli N, Mouquet H, Bruel T, Schwartz O. Syncytia formation by SARS-CoV-2-infected cells. The Embo Journal. 40: e107405. PMID 33522642 DOI: 10.15252/embj.2020107405  0.312
2020 Lorin V, Danckaert A, Porrot F, Schwartz O, Afonso PV, Mouquet H. Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier. Mbio. 11. PMID 33082263 DOI: 10.1128/mBio.02424-20  0.409
2020 Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Michael Rajah M, Planchais C, Porrot F, Guivel-Benhassine F, Van der Werf S, Casartelli N, Mouquet H, Bruel T, Schwartz O. Syncytia formation by SARS-CoV-2 infected cells. The Embo Journal. e106267. PMID 33051876 DOI: 10.15252/embj.2020106267  0.369
2020 Grzelak L, Temmam S, Planchais C, Demeret C, Tondeur L, Huon C, Guivel-Benhassine F, Staropoli I, Chazal M, Dufloo J, Planas D, Buchrieser J, Rajah MM, Robinot R, Porrot F, ... ... Schwartz O, et al. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations. Science Translational Medicine. PMID 32817357 DOI: 10.1126/Scitranslmed.Abc3103  0.316
2020 Fafi-Kremer S, Bruel T, Madec Y, Grant R, Tondeur L, Grzelak L, Staropoli I, Anna F, Souque P, Fernandes-Pellerin S, Jolly N, Renaudat C, Ungeheuer MN, Schmidt-Mutter C, Collongues N, ... ... Schwartz O, et al. Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France. Ebiomedicine. 102915. PMID 32747185 DOI: 10.1016/J.Ebiom.2020.102915  0.331
2020 Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, O'Meara MJ, Guo JZ, Swaney DL, Tummino TA, Hüttenhain R, Kaake RM, Richards AL, Tutuncuoglu B, Foussard H, Batra J, ... ... Schwartz O, et al. A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing. Biorxiv : the Preprint Server For Biology. PMID 32511329 DOI: 10.1101/2020.03.22.002386  0.581
2020 Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O'Meara MJ, Rezelj VV, Guo JZ, Swaney DL, Tummino TA, Huettenhain R, Kaake RM, Richards AL, Tutuncuoglu B, ... ... Schwartz O, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. PMID 32353859 DOI: 10.1038/S41586-020-2286-9  0.596
2020 Blanco-Rodriguez G, Gazi A, Monel B, Frabetti S, Scoca V, Mueller F, Schwartz O, Krijnse-Locker J, Charneau P, Di Nunzio F. Remodeling of the core leads HIV-1 pre-integration complex in the nucleus of human lymphocytes. Journal of Virology. PMID 32238582 DOI: 10.1016/S2055-6640(20)30076-5  0.498
2020 Hellert J, Buchrieser J, Larrous F, Minola A, de Melo GD, Soriaga L, England P, Haouz A, Telenti A, Schwartz O, Corti D, Bourhy H, Rey FA. Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein. Nature Communications. 11: 596. PMID 32001700 DOI: 10.1038/S41467-020-14398-7  0.364
2020 Labeau A, Simon-Loriere E, Hafirassou ML, Bonnet-Madin L, Tessier S, Zamborlini A, Dupré T, Seta N, Schwartz O, Chaix ML, Delaugerre C, Amara A, Meertens L. A genome-wide CRISPR-Cas9 screen identifies the dolichol-phosphate mannose synthase complex as a host dependency factor for dengue virus infection. Journal of Virology. PMID 31915280 DOI: 10.1128/Jvi.01751-19  0.468
2020 Le Hingrat Q, Visseaux B, Bertine M, Chauveau L, Schwartz O, Collin F, Damond F, Matheron S, Descamps D, Charpentier C. Genetic variability of Long Terminal Repeat region between HIV-2 groups impacts transcriptional activity. Journal of Virology. PMID 31915276 DOI: 10.1128/Jvi.01504-19  0.525
2019 Staropoli I, Dufloo J, Ducher A, Commere PH, Sartori-Rupp A, Novault S, Bruel T, Lorin V, Mouquet H, Schwartz O, Casartelli N. Flow-cytometry analysis of HIV-1 Env conformations at the surface of infected cells and virions: role of Nef, CD4 and SERINC5. Journal of Virology. PMID 31852789 DOI: 10.1128/Jvi.01783-19  0.572
2019 Dufloo J, Guivel-Benhassine F, Buchrieser J, Lorin V, Grzelak L, Dupouy E, Mestrallet G, Bourdic K, Lambotte O, Mouquet H, Bruel T, Schwartz O. Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells. Embo Reports. e49351. PMID 31833228 DOI: 10.15252/Embr.201949351  0.564
2019 Ruigrok K, Vaney MC, Buchrieser J, Baquero E, Hellert J, Baron B, England P, Schwartz O, Rey FA, Backovic M. X-ray structures of the post-fusion 6-helix bundle of the human syncytins and their functional implications. Journal of Molecular Biology. PMID 31711961 DOI: 10.1016/J.Jmb.2019.10.020  0.333
2019 Pinto D, Fenwick C, Caillat C, Silacci C, Guseva S, Dehez F, Chipot C, Barbieri S, Minola A, Jarrossay D, Tomaras GD, Shen X, Riva A, Tarkowski M, Schwartz O, et al. Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01. Cell Host & Microbe. PMID 31653484 DOI: 10.1016/J.Chom.2019.09.016  0.431
2019 Passos V, Zillinger T, Casartelli N, Wachs AS, Xu S, Malassa A, Steppich K, Schilling H, Franz S, Todt D, Steinmann E, Sutter K, Dittmer U, Bohne J, Schwartz O, et al. Characterization of Endogenous SERINC5 Protein as anti-HIV-1 Factor. Journal of Virology. PMID 31597782 DOI: 10.1128/JVI.01221-19  0.512
2019 Monel B, Rajah MM, Hafirassou ML, Sid-Ahmed S, Burlaud-Gaillard J, Zhu PP, Nevers Q, Buchrieser J, Porrot F, Meunier C, Amraoui S, Chazal M, Salles A, Jouvenet N, Roingeard P, ... ... Schwartz O, et al. The Atlastin ER-shaping proteins facilitate Zika virus replication. Journal of Virology. PMID 31534046 DOI: 10.1128/Jvi.01047-19  0.463
2019 Buchrieser J, Degrelle SA, Couderc T, Nevers Q, Disson O, Manet C, Donahue DA, Porrot F, Hillion KH, Perthame E, Arroyo MV, Souquere S, Ruigrok K, Dupressoir A, Heidmann T, ... ... Schwartz O, et al. IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise. Science (New York, N.Y.). 365: 176-180. PMID 31296770 DOI: 10.1126/Science.Aaw7733  0.369
2019 Hani L, Chaillon A, Nere ML, Ruffin N, Alameddine J, Salmona M, Lopez Zaragoza JL, Smith DM, Schwartz O, Lelièvre JD, Delaugerre C, Lévy Y, Seddiki N. Proliferative memory SAMHD1low CD4+ T cells harbour high levels of HIV-1 with compartmentalized viral populations. Plos Pathogens. 15: e1007868. PMID 31220191 DOI: 10.1371/Journal.Ppat.1007868  0.527
2019 Bruel T, Schwartz O. HIV-1 Envelope FRETted Over by Antibodies. Cell Host & Microbe. 25: 767-768. PMID 31194935 DOI: 10.1016/J.Chom.2019.05.009  0.416
2019 Planchais C, Kök A, Kanyavuz A, Lorin V, Bruel T, Guivel-Benhassine F, Rollenske T, Prigent J, Hieu T, Prazuck T, Lefrou L, Wardemann H, Schwartz O, Dimitrov JD, Hocqueloux L, et al. HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells. Cell Reports. 27: 572-585.e7. PMID 30970259 DOI: 10.1016/J.Celrep.2019.03.032  0.49
2019 Masse-Ranson G, Dusséaux M, Fiquet O, Darche S, Boussand M, Li Y, Lopez-Lastra S, Legrand N, Corcuff E, Toubert A, Centlivre M, Bruel T, Spits H, Schwartz O, Lévy Y, et al. Accelerated thymopoiesis and improved T cell responses in HLA-A2/-DR2 transgenic BRGS-based human immune system mice. European Journal of Immunology. PMID 30888052 DOI: 10.1002/Eji.201848001  0.376
2018 Li Y, Masse-Ranson G, Garcia Z, Bruel T, Kök A, Strick-Marchand H, Jouvion G, Serafini N, Lim AI, Dusseaux M, Hieu T, Bourgade F, Toubert A, Finke D, Schwartz O, et al. A human immune system mouse model with robust lymph node development. Nature Methods. 15: 623-630. PMID 30065364 DOI: 10.1038/S41592-018-0071-6  0.41
2018 Dufloo J, Bruel T, Schwartz O. HIV-1 cell-to-cell transmission and broadly neutralizing antibodies. Retrovirology. 15: 51. PMID 30055632 DOI: 10.1186/S12977-018-0434-1  0.59
2018 Prigent J, Jarossay A, Planchais C, Eden C, Dufloo J, Kök A, Lorin V, Vratskikh O, Couderc T, Bruel T, Schwartz O, Seaman MS, Ohlenschläger O, Dimitrov JD, Mouquet H. Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity. Cell Reports. 23: 2568-2581. PMID 29847789 DOI: 10.1016/J.Celrep.2018.04.101  0.475
2018 Bruel T, Schwartz O. Markers of the HIV-1 reservoir: facts and controversies. Current Opinion in Hiv and Aids. PMID 29846244 DOI: 10.1097/Coh.0000000000000482  0.533
2018 Dejarnac O, Hafirassou ML, Chazal M, Versapuech M, Gaillard J, Perera-Lecoin M, Umana-Diaz C, Bonnet-Madin L, Carnec X, Tinevez JY, Delaugerre C, Schwartz O, Roingeard P, Jouvenet N, Berlioz-Torrent C, et al. TIM-1 Ubiquitination Mediates Dengue Virus Entry. Cell Reports. 23: 1779-1793. PMID 29742433 DOI: 10.1016/J.Celrep.2018.04.013  0.453
2017 Shi G, Schwartz O, Compton AA. More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins. Retrovirology. 14: 53. PMID 29162141 DOI: 10.1186/S12977-017-0377-Y  0.759
2017 Chesarino NM, Compton AA, McMichael TM, Kenney AD, Zhang L, Soewarna V, Davis M, Schwartz O, Yount JS. IFITM3 requires an amphipathic helix for antiviral activity. Embo Reports. PMID 28835547 DOI: 10.15252/Embr.201744100  0.703
2017 Chauveau L, Donahue DA, Monel B, Porrot F, Bruel T, Richard L, Casartelli N, Schwartz O. HIV fusion in Dendritic cells mainly occurs at the surface and is limited by low CD4 levels. Journal of Virology. PMID 28814521 DOI: 10.1128/Jvi.01248-17  0.582
2017 Descours B, Petitjean G, López-Zaragoza JL, Bruel T, Raffel R, Psomas C, Reynes J, Lacabaratz C, Levy Y, Schwartz O, Daniel Lelievre J, Benkirane M. Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. 546: 686. PMID 28658234 DOI: 10.1038/Nature22807  0.486
2017 Monel B, Compton AA, Bruel T, Amraoui S, Burlaud-Gaillard J, Roy N, Guivel-Benhassine F, Porrot F, Génin P, Meertens L, Sinigaglia L, Jouvenet N, Weil R, Casartelli N, Demangel C, ... ... Schwartz O, et al. Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells. The Embo Journal. PMID 28473450 DOI: 10.15252/Embj.201695597  0.73
2017 Lorin V, Malbec M, Eden C, Bruel T, Porrot F, Seaman MS, Schwartz O, Mouquet H. Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity. Mucosal Immunology. 10: 829. PMID 28435154 DOI: 10.1038/mi.2017.39  0.39
2017 Descours B, Petitjean G, López-Zaragoza JL, Bruel T, Raffel R, Psomas C, Reynes J, Lacabaratz C, Levy Y, Schwartz O, Lelievre JD, Benkirane M. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature. PMID 28297712 DOI: 10.1038/Nature21710  0.576
2017 Zhivaki D, Lemoine S, Lim A, Morva A, Vidalain PO, Schandene L, Casartelli N, Rameix-Welti MA, Hervé PL, Dériaud E, Beitz B, Ripaux-Lefevre M, Miatello J, Lemercier B, Lorin V, ... ... Schwartz O, et al. Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity. Immunity. 46: 301-314. PMID 28228284 DOI: 10.1016/j.immuni.2017.01.010  0.331
2017 Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, Dy M, Scott-Algara D, Manoury B, Zirafi O, McCort-Tranchepain I, Durroux T, Bachelerie F, Schwartz O, Münch J, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nature Communications. 8: 14253. PMID 28181493 DOI: 10.1038/Ncomms14253  0.411
2017 Compton AA, Schwartz O. They Might Be Giants: Does Syncytium Formation Sink or Spread HIV Infection? Plos Pathogens. 13: e1006099. PMID 28152024 DOI: 10.1371/Journal.Ppat.1006099  0.737
2017 Bruel T, Guivel-Benhassine F, Lorin V, Lortat-Jacob H, Baleux F, Bourdic K, Noël N, Lambotte O, Mouquet H, Schwartz O. Lack of ADCC breadth of human non-neutralizing anti-HIV-1 antibodies. Journal of Virology. PMID 28122982 DOI: 10.1128/Jvi.02440-16  0.538
2017 Pereira Bittencourt Passaes C, Bruel T, Decalf J, David A, Angin M, Monceaux V, Muller-Trutwin M, Noel N, Bourdic K, Lambotte O, Albert ML, Duffy D, Schwartz O, Sáez-Cirión A. Ultrasensitive HIV-1 p24 detects single infected cells and differences in reservoir induction by latency-reversal agents. Journal of Virology. PMID 28077644 DOI: 10.1128/Jvi.02296-16  0.564
2017 Donahue DA, Porrot F, Couespel N, Schwartz O. SUN2 silencing impairs CD4 T cell proliferation and alters sensitivity to HIV-1 infection independently of Cyclophilin A. Journal of Virology. PMID 28077629 DOI: 10.1128/Jvi.02303-16  0.579
2017 Meertens L, Labeau A, Dejarnac O, Cipriani S, Sinigaglia L, Bonnet-Madin L, Le Charpentier T, Hafirassou ML, Zamborlini A, Cao-Lormeau VM, Coulpier M, Missé D, Jouvenet N, Tabibiazar R, Gressens P, ... Schwartz O, et al. Axl Mediates ZIKA Virus Entry in Human Glial Cells and Modulates Innate Immune Responses. Cell Reports. 18: 324-333. PMID 28076778 DOI: 10.1016/J.Celrep.2016.12.045  0.492
2016 Lorin V, Malbec M, Eden C, Bruel T, Porrot F, Seaman MS, Schwartz O, Mouquet H. Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity. Mucosal Immunology. PMID 27966557 DOI: 10.1038/Mi.2016.106  0.549
2016 Ariën KK, Baleux F, Desjardins D, Porrot F, Coïc YM, Michiels J, Bouchemal K, Bonnaffé D, Bruel T, Schwartz O, Le Grand R, Vanham G, Dereuddre-Bosquet N, Lortat-Jacob H. CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge. Scientific Reports. 6: 34829. PMID 27721488 DOI: 10.1038/Srep34829  0.457
2016 Bruel T, Mouquet H, Schwartz O. [Antibodies that kill HIV-1-infected cells]. MéDecine Sciences : M/S. 32: 671-4. PMID 27615165 DOI: 10.1051/Medsci/20163208004  0.527
2016 Compton AA, Roy N, Porrot F, Billet A, Casartelli N, Yount JS, Liang C, Schwartz O. Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity. Embo Reports. PMID 27601221 DOI: 10.15252/Embr.201642771  0.766
2016 Chauveau L, Schwartz O. [A mystery solved: HIV-1 Nef targets SERINC3 and SERINC5]. Medecine Sciences : M/S. 32: 560-562. PMID 27406758 DOI: 10.1051/Medsci/20163206011  0.439
2016 Coulon PG, Richetta C, Rouers A, Blanchet FP, Urrutia A, Guerbois M, Piguet V, Theodorou I, Bet A, Schwartz O, Tangy F, Graff-Dubois S, Cardinaud S, Moris A. HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 27288536 DOI: 10.4049/Jimmunol.1600286  0.556
2016 Lahouassa H, Blondot ML, Chauveau L, Chougui G, Morel M, Leduc M, Guillonneau F, Ramirez BC, Schwartz O, Margottin-Goguet F. HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages. Proceedings of the National Academy of Sciences of the United States of America. 113: 5311-6. PMID 27114546 DOI: 10.1073/Pnas.1600485113  0.494
2016 Donahue DA, Schwartz O. Actin' on HIV: How Dendritic Cells Spread Infection. Cell Host & Microbe. 19: 267-9. PMID 26962935 DOI: 10.1016/J.Chom.2016.02.016  0.569
2016 Bruel T, Guivel-Benhassine F, Amraoui S, Malbec M, Richard L, Bourdic K, Donahue DA, Lorin V, Casartelli N, Noël N, Lambotte O, Mouquet H, Schwartz O. Elimination of HIV-1-infected cells by broadly neutralizing antibodies. Nature Communications. 7: 10844. PMID 26936020 DOI: 10.1038/Ncomms10844  0.543
2016 Donahue DA, Amraoui S, di Nunzio F, Kieffer C, Porrot F, Opp S, Diaz-Griffero F, Casartelli N, Schwartz O. SUN2 overexpression deforms nuclear shape and inhibits HIV. Journal of Virology. PMID 26865710 DOI: 10.1128/Jvi.03202-15  0.576
2016 Bruel T, Guivel-Benhassine F, Amraoui S, Malbec M, Richard L, Bourdic K, Donahue DA, Lorin V, Casartelli N, Noël N, Lambotte O, Mouquet H, Schwartz O. Elimination of HIV-1-infected cells by broadly neutralizing antibodies Nature Communications. 7. DOI: 10.1038/ncomms10844  0.455
2016 Bressollette-Bodin C, Peltier C, Chauveau L, Schwartz O. BK polyomavirus infection activates the type I interferon response in human fibroblasts, depending on the cGAS-STING pathway Journal of Clinical Virology. 82. DOI: 10.1016/J.Jcv.2016.08.200  0.367
2016 Donahue DA, Schwartz O. Actin' on HIV: How Dendritic Cells Spread Infection Cell Host and Microbe. 19: 267-269. DOI: 10.1016/j.chom.2016.02.016  0.485
2015 Carnec X, Meertens L, Dejarnac O, Perera-Lecoin M, Lamine Hafirassou M, Kitaura J, Ramdasi R, Schwartz O, Amara A. The phosphatidylserine and phosphatidylethanolamine receptor CD300a binds dengue virus and enhances infection. Journal of Virology. PMID 26468529 DOI: 10.1128/Jvi.01849-15  0.499
2015 Roesch F, Richard L, Rua R, Porrot F, Casartelli N, Schwartz O. Vpr enhances TNF production by HIV-1 infected T cells. Journal of Virology. PMID 26401039 DOI: 10.1128/Jvi.02098-15  0.577
2015 Joubert PE, Stapleford K, Guivel-Benhassine F, Vignuzzi M, Schwartz O, Albert ML. Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway. Plos Pathogens. 11: e1005091. PMID 26317997 DOI: 10.1371/Journal.Ppat.1005091  0.431
2015 Ayinde D, Bruel T, Cardinaud S, Porrot F, Prado JG, Moris A, Schwartz O. SAMHD1 limits HIV-1 antigen presentation by monocyte-derived dendritic cells. Journal of Virology. PMID 25926647 DOI: 10.1128/Jvi.00069-15  0.588
2015 Jochems SP, Jacquelin B, Chauveau L, Huot N, Petitjean G, Lepelley A, Liovat AS, Ploquin MJ, Cartwright EK, Bosinger SE, Silvestri G, Barré-Sinoussi F, Lebon P, Schwartz O, Müller-Trutwin MC. Plasmacytoid Dendritic Cell Infection and Sensing Capacity during Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infection. Journal of Virology. 89: 6918-27. PMID 25903334 DOI: 10.1128/Jvi.00332-15  0.566
2015 Bruni D, Chazal M, Sinigaglia L, Chauveau L, Schwartz O, Desprès P, Jouvenet N. Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons. Science Signaling. 8: ra25. PMID 25737587 DOI: 10.1126/Scisignal.Aaa1552  0.435
2015 Ruffin N, Brezar V, Ayinde D, Lefebvre C, Schulze Zur Wiesch J, van Lunzen J, Bockhorn M, Schwartz O, Hocini H, Lelievre JD, Banchereau J, Levy Y, Seddiki N. Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1. Aids (London, England). 29: 519-30. PMID 25715102 DOI: 10.1097/Qad.0000000000000594  0.538
2015 El-Far M, Ancuta P, Routy JP, Zhang Y, Bakeman W, Bordi R, DaFonseca S, Said EA, Gosselin A, Tep TS, Eichbaum Q, van Grevenynghe J, Schwartz O, Freeman GJ, Haddad EK, et al. Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation. The Journal of General Virology. 96: 1463-77. PMID 25626682 DOI: 10.1099/Vir.0.000065  0.592
2015 Chauveau L, Puigdomenech I, Ayinde D, Roesch F, Porrot F, Bruni D, Visseaux B, Descamps D, Schwartz O. HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells. Retrovirology. 12: 2. PMID 25582927 DOI: 10.1186/S12977-014-0131-7  0.618
2015 Quillay H, El Costa H, Marlin R, Duriez M, Cannou C, Chrétien F, Fernandez H, Lebreton A, Ighil J, Schwartz O, Barré-Sinoussi F, Nugeyre MT, Menu E. Distinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1. Journal of Virology. 89: 1329-39. PMID 25392215 DOI: 10.1128/Jvi.01730-14  0.565
2015 Billet A, Compton AA, Schwartz O. The IFITM protein family: Antiviral effects and cellular functions | La famille des protéines IFITM : Effets antiviraux et fonctions cellulaires Virologie. 19: 251-260. DOI: 10.1684/Vir.2015.0625  0.745
2014 Compton AA, Bruel T, Porrot F, Mallet A, Sachse M, Euvrard M, Liang C, Casartelli N, Schwartz O. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread. Cell Host & Microbe. 16: 736-47. PMID 25464829 DOI: 10.1016/J.Chom.2014.11.001  0.788
2014 Malbec M, Mouquet H, Schwartz O. [HIV-1 cell-to-cell transmission and broadly neutralizing antibodies]. Mã©Decine Sciences : M/S. 30: 508-10. PMID 24939535 DOI: 10.1051/Medsci/20143005011  0.493
2014 Briolat V, Jouneau L, Carvalho R, Palha N, Langevin C, Herbomel P, Schwartz O, Spaink HP, Levraud JP, Boudinot P. Contrasted innate responses to two viruses in zebrafish: insights into the ancestral repertoire of vertebrate IFN-stimulated genes. Journal of Immunology (Baltimore, Md. : 1950). 192: 4328-41. PMID 24683187 DOI: 10.4049/Jimmunol.1302611  0.41
2014 Zhang X, Casartelli N, Lemoine S, Mozeleski B, Azria E, Le Ray C, Schwartz O, Launay O, Leclerc C, Lo-Man R. Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings. The Journal of Infectious Diseases. 210: 424-34. PMID 24558121 DOI: 10.1093/Infdis/Jiu103  0.357
2014 Vabret N, Bailly-Bechet M, Lepelley A, Najburg V, Schwartz O, Verrier B, Tangy F. Large-scale nucleotide optimization of simian immunodeficiency virus reduces its capacity to stimulate type I interferon in vitro. Journal of Virology. 88: 4161-72. PMID 24478441 DOI: 10.1128/Jvi.03223-13  0.411
2013 Malbec M, Porrot F, Rua R, Horwitz J, Klein F, Halper-Stromberg A, Scheid JF, Eden C, Mouquet H, Nussenzweig MC, Schwartz O. Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission. The Journal of Experimental Medicine. 210: 2813-21. PMID 24277152 DOI: 10.1084/Jem.20131244  0.557
2013 Cruz DJ, Bonotto RM, Gomes RG, da Silva CT, Taniguchi JB, No JH, Lombardot B, Schwartz O, Hansen MA, Freitas-Junior LH. Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library. Plos Neglected Tropical Diseases. 7: e2471. PMID 24205414 DOI: 10.1371/Journal.Pntd.0002471  0.436
2013 Horwitz JA, Halper-Stromberg A, Mouquet H, Gitlin AD, Tretiakova A, Eisenreich TR, Malbec M, Gravemann S, Billerbeck E, Dorner M, Büning H, Schwartz O, Knops E, Kaiser R, Seaman MS, et al. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proceedings of the National Academy of Sciences of the United States of America. 110: 16538-43. PMID 24043801 DOI: 10.1073/Pnas.1315295110  0.492
2013 Palha N, Guivel-Benhassine F, Briolat V, Lutfalla G, Sourisseau M, Ellett F, Wang CH, Lieschke GJ, Herbomel P, Schwartz O, Levraud JP. Real-time whole-body visualization of Chikungunya Virus infection and host interferon response in zebrafish. Plos Pathogens. 9: e1003619. PMID 24039582 DOI: 10.1371/Journal.Ppat.1003619  0.454
2013 Roesch F, Schwartz O. The SAMHD1 knockout mouse model: in vivo veritas? The Embo Journal. 32: 2427-9. PMID 23963314 DOI: 10.1038/Emboj.2013.190  0.511
2013 Malbec M, Sourisseau M, Guivel-Benhassine F, Porrot F, Blanchet F, Schwartz O, Casartelli N. HIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer. Retrovirology. 10: 80. PMID 23899341 DOI: 10.1186/1742-4690-10-80  0.545
2013 Castelli FA, Szely N, Olivain A, Casartelli N, Grygar C, Schneider A, Besse A, Levy Y, Schwartz O, Maillère B. Hierarchy of CD4 T cell epitopes of the ANRS Lipo5 synthetic vaccine relies on the frequencies of pre-existing peptide-specific T cells in healthy donors. Journal of Immunology (Baltimore, Md. : 1950). 190: 5757-63. PMID 23636059 DOI: 10.4049/Jimmunol.1300145  0.415
2013 El-Far M, Isabelle C, Chomont N, Bourbonnière M, Fonseca S, Ancuta P, Peretz Y, Chouikh Y, Halwani R, Schwartz O, Madrenas J, Freeman GJ, Routy JP, Haddad EK, Sékaly RP. Down-regulation of CTLA-4 by HIV-1 Nef protein. Plos One. 8: e54295. PMID 23372701 DOI: 10.1371/Journal.Pone.0054295  0.525
2013 Zhang X, Lepelley A, Azria E, Lebon P, Roguet G, Schwartz O, Launay O, Leclerc C, Lo-Man R. Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses. Plos One. 8: e52003. PMID 23326320 DOI: 10.1371/Journal.Pone.0052003  0.435
2013 Puigdomènech I, Casartelli N, Porrot F, Schwartz O. SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells. Journal of Virology. 87: 2846-56. PMID 23269793 DOI: 10.1128/Jvi.02514-12  0.622
2013 Roesch F, Schwartz O. Quantification of HIV-1 DNA Bio-Protocol. 3. DOI: 10.21769/BIOPROTOC.417  0.302
2013 Roesch F, Schwartz O. HIV-1 Single Cycle Infection Bio-Protocol. 3. DOI: 10.21769/BIOPROTOC.416  0.404
2013 Schwartz O. HIV cell-to-cell spread and innate immune responses Retrovirology. 10: 1-1. DOI: 10.1186/1742-4690-10-S1-O34  0.589
2012 Descours B, Cribier A, Chable-Bessia C, Ayinde D, Rice G, Crow Y, Yatim A, Schwartz O, Laguette N, Benkirane M. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology. 9: 87. PMID 23092122 DOI: 10.1186/1742-4690-9-87  0.532
2012 Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, Lew E, Lemke G, Schwartz O, Amara A. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host & Microbe. 12: 544-57. PMID 23084921 DOI: 10.1016/J.Chom.2012.08.009  0.453
2012 Garcia Z, Lemaître F, van Rooijen N, Albert ML, Levy Y, Schwartz O, Bousso P. Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles. Blood. 120: 4744-50. PMID 23065157 DOI: 10.1182/Blood-2012-02-408179  0.435
2012 Ayinde D, Casartelli N, Schwartz O. Restricting HIV the SAMHD1 way: through nucleotide starvation. Nature Reviews. Microbiology. 10: 675-80. PMID 22926205 DOI: 10.1038/Nrmicro2862  0.556
2012 Joubert PE, Werneke S, de la Calle C, Guivel-Benhassine F, Giodini A, Peduto L, Levine B, Schwartz O, Lenschow D, Albert ML. Chikungunya-induced cell death is limited by ER and oxidative stress-induced autophagy. Autophagy. 8: 1261-3. PMID 22836517 DOI: 10.4161/Auto.20751  0.358
2012 Roesch F, Meziane O, Kula A, Nisole S, Porrot F, Anderson I, Mammano F, Fassati A, Marcello A, Benkirane M, Schwartz O. Hyperthermia stimulates HIV-1 replication. Plos Pathogens. 8: e1002792. PMID 22807676 DOI: 10.1371/Journal.Ppat.1002792  0.552
2012 Martin-Latil S, Gnädig NF, Mallet A, Desdouits M, Guivel-Benhassine F, Jeannin P, Prevost MC, Schwartz O, Gessain A, Ozden S, Ceccaldi PE. Transcytosis of HTLV-1 across a tight human epithelial barrier and infection of subepithelial dendritic cells. Blood. 120: 572-80. PMID 22589473 DOI: 10.1182/Blood-2011-08-374637  0.444
2012 Joubert PE, Werneke SW, de la Calle C, Guivel-Benhassine F, Giodini A, Peduto L, Levine B, Schwartz O, Lenschow DJ, Albert ML. Chikungunya virus-induced autophagy delays caspase-dependent cell death. The Journal of Experimental Medicine. 209: 1029-47. PMID 22508836 DOI: 10.1084/Jem.20110996  0.384
2012 Schilte C, Buckwalter MR, Laird ME, Diamond MS, Schwartz O, Albert ML. Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection. Journal of Immunology (Baltimore, Md. : 1950). 188: 2967-71. PMID 22371392 DOI: 10.4049/Jimmunol.1103185  0.47
2012 Monel B, Beaumont E, Vendrame D, Schwartz O, Brand D, Mammano F. HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores. Journal of Virology. 86: 3924-33. PMID 22258237 DOI: 10.1128/Jvi.06478-11  0.573
2012 Rua R, Lepelley A, Gessain A, Schwartz O. Innate sensing of foamy viruses by human hematopoietic cells. Journal of Virology. 86: 909-18. PMID 22090096 DOI: 10.1128/Jvi.06235-11  0.494
2011 Malbec M, Roesch F, Schwartz O. A new role for the HTLV-1 p8 protein: increasing intercellular conduits and viral cell-to-cell transmission. Viruses. 3: 254-9. PMID 21994729 DOI: 10.3390/V3030254  0.513
2011 Genovesio A, Kwon YJ, Windisch MP, Kim NY, Choi SY, Kim HC, Jung S, Mammano F, Perrin V, Boese AS, Casartelli N, Schwartz O, Nehrbass U, Emans N. Automated genome-wide visual profiling of cellular proteins involved in HIV infection. Journal of Biomolecular Screening. 16: 945-58. PMID 21841144 DOI: 10.1177/1087057111415521  0.555
2011 Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Ségéral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature. 474: 654-7. PMID 21613998 DOI: 10.1038/Nature10117  0.604
2011 Cardinaud S, Consiglieri G, Bouziat R, Urrutia A, Graff-Dubois S, Fourati S, Malet I, Guergnon J, Guihot A, Katlama C, Autran B, van Endert P, Lemonnier FA, Appay V, Schwartz O, et al. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope. Plos Pathogens. 7: e1002049. PMID 21589903 DOI: 10.1371/Journal.Ppat.1002049  0.485
2011 Lepelley A, Louis S, Sourisseau M, Law HK, Pothlichet J, Schilte C, Chaperot L, Plumas J, Randall RE, Si-Tahar M, Mammano F, Albert ML, Schwartz O. Innate sensing of HIV-infected cells. Plos Pathogens. 7: e1001284. PMID 21379343 DOI: 10.1371/Journal.Ppat.1001284  0.607
2011 Schwartz O. Novel insights into innate sensing of HIV-infected cells Retrovirology. 8: 1-1. DOI: 10.1186/1742-4690-8-S2-O13  0.611
2011 Rua R, Lepelley A, Gessain A, Schwartz O. Innate response to Foamy viruses Retrovirology. 8: 1-1. DOI: 10.1186/1742-4690-8-S1-A239  0.384
2011 Chable-Bessia C, Meziane O, D C, Emiliani S, Schwartz O, Lambotte O, Lévy Y, Autran B, Reynes J, Bennasser Y, Benkirane M. 122 Interplay Between HIV Replication and MicroRNAs Journal of Acquired Immune Deficiency Syndromes. 56: 49. DOI: 10.1097/01.Qai.0000397310.79094.E8  0.48
2010 Feldmann J, Schwartz O. HIV-1 Virological Synapse: Live Imaging of Transmission. Viruses. 2: 1666-80. PMID 21994700 DOI: 10.3390/V2081666  0.497
2010 Casartelli N, Sourisseau M, Feldmann J, Guivel-Benhassine F, Mallet A, Marcelin AG, Guatelli J, Schwartz O. Tetherin restricts productive HIV-1 cell-to-cell transmission. Plos Pathogens. 6: e1000955. PMID 20585562 DOI: 10.1371/Journal.Ppat.1000955  0.588
2010 Schwartz O, Albert ML. Biology and pathogenesis of chikungunya virus. Nature Reviews. Microbiology. 8: 491-500. PMID 20551973 DOI: 10.1038/Nrmicro2368  0.382
2010 Blanchet FP, Moris A, Nikolic DS, Lehmann M, Cardinaud S, Stalder R, Garcia E, Dinkins C, Leuba F, Wu L, Schwartz O, Deretic V, Piguet V. Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity. 32: 654-69. PMID 20451412 DOI: 10.1016/J.Immuni.2010.04.011  0.536
2010 Brandler S, Lepelley A, Desdouits M, Guivel-Benhassine F, Ceccaldi PE, Lévy Y, Schwartz O, Moris A. Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect. Journal of Virology. 84: 5314-28. PMID 20219934 DOI: 10.1128/Jvi.02329-09  0.62
2010 Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, et al. Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. The Journal of Experimental Medicine. 207: 429-42. PMID 20123960 DOI: 10.1084/Jem.20090851  0.463
2010 Casartelli N, Guivel-Benhassine F, Bouziat R, Brandler S, Schwartz O, Moris A. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells. The Journal of Experimental Medicine. 207: 39-49. PMID 20038599 DOI: 10.1084/Jem.20091933  0.546
2010 Nobile C, Rudnicka D, Hasan M, Aulner N, Porrot F, Machu C, Renaud O, Prévost MC, Hivroz C, Schwartz O, Sol-Foulon N. HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes. Journal of Virology. 84: 2282-93. PMID 20015995 DOI: 10.1128/Jvi.02230-09  0.552
2009 Vendrame D, Sourisseau M, Perrin V, Schwartz O, Mammano F. Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer. Journal of Virology. 83: 10527-37. PMID 19706714 DOI: 10.1128/Jvi.01235-09  0.601
2009 Rudnicka D, Schwartz O. Intrusive HIV-1-infected cells. Nature Immunology. 10: 933-4. PMID 19692990 DOI: 10.1038/Ni0909-933  0.586
2009 Fausther-Bovendo H, Sol-Foulon N, Candotti D, Agut H, Schwartz O, Debré P, Vieillard V. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells. Aids (London, England). 23: 1077-87. PMID 19424050 DOI: 10.1097/Qad.0B013E32832Cb26B  0.598
2009 Rudnicka D, Feldmann J, Porrot F, Wietgrefe S, Guadagnini S, Prévost MC, Estaquier J, Haase AT, Sol-Foulon N, Schwartz O. Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. Journal of Virology. 83: 6234-46. PMID 19369333 DOI: 10.1128/Jvi.00282-09  0.61
2009 Guerbois M, Moris A, Combredet C, Najburg V, Ruffié C, Février M, Cayet N, Brandler S, Schwartz O, Tangy F. Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic. Virology. 388: 191-203. PMID 19345390 DOI: 10.1016/J.Virol.2009.02.047  0.533
2009 Garcia JM, Gao A, He PL, Choi J, Tang W, Bruzzone R, Schwartz O, Naya H, Nan FJ, Li J, Altmeyer R, Zuo JP. High-throughput screening using pseudotyped lentiviral particles: a strategy for the identification of HIV-1 inhibitors in a cell-based assay. Antiviral Research. 81: 239-47. PMID 19118579 DOI: 10.1016/J.Antiviral.2008.12.004  0.463
2009 Martin-Latil S, Gnädig N, Mallet A, Prevost M, Desdouits M, Schwartz O, Gessain A, Ozden S, Ceccaldi P. Mother-to-child transmission of HTLV-1:in vitro study of HTLV-1 passage across a tight human epithelial barrier. Retrovirology. 8: 1-1. DOI: 10.1186/1742-4690-8-S1-A194  0.407
2009 Brandler S, Desdouits M, Ceccaldi P, Lévy Y, Schwartz O, Moris A. P19-19. MVA vaccines are efficiently cross-presented by DCs and do not enhance HIV replication in DC/T cell cultures Retrovirology. 6: 339. DOI: 10.1186/1742-4690-6-S3-P339  0.417
2009 Lepelley A, Louis S, Sourisseau M, Perrin V, Mammano F, Albert M, Schwartz O. P10-04. Mechanisms of HIV-1 detection by plasmacytoid dendritic cells Retrovirology. 6: 135. DOI: 10.1186/1742-4690-6-S3-P135  0.472
2009 Fausther-Bovendo H, Sol-Foulon N, Schwartz O, Debre P, Vieillard V. OA031-05. HIV escape from natural killer cytotoxicity: Nef inhibits NKp44L expression on HIV-infected CD4+ T cells Retrovirology. 6: 1-1. DOI: 10.1186/1742-4690-6-S3-O23  0.562
2009 Tangy F, Février M, Guerbois M, Combredet C, Najburg V, Ruffié C, Morris A, Schwartz O, Legrand R. OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV Retrovirology. 6: 1-1. DOI: 10.1186/1742-4690-6-S3-O14  0.387
2009 Vendrame D, Sourisseau M, Perrin V, Schwartz O, Mammano F. Partial inhibition of HIV replication by type-I interferons: impact of cell-to-cell viral transfer Retrovirology. 6: 1-1. DOI: 10.1186/1742-4690-6-S2-O23  0.58
2009 Schwartz O. Immunological and virological aspects of HIV cell-to-cell transfer Retrovirology. 6. DOI: 10.1186/1742-4690-6-S2-I16  0.6
2008 Dorival C, Brizzi F, Lelièvre JD, Sol-Foulon N, Six E, Henry A, André-Schmutz I, Cavazzana-Calvo M, Coulombel L, Estaquier J, Schwartz O, Lévy Y. HIV-1 Nef protein expression in human CD34+ progenitors impairs the differentiation of an early T/NK cell precursor. Virology. 377: 207-15. PMID 18555888 DOI: 10.1016/J.Virol.2008.04.009  0.451
2008 Zhang P, Skurnik M, Zhang SS, Schwartz O, Kalyanasundaram R, Bulgheresi S, He JJ, Klena JD, Hinnebusch BJ, Chen T. Human dendritic cell-specific intercellular adhesion molecule-grabbing nonintegrin (CD209) is a receptor for Yersinia pestis that promotes phagocytosis by dendritic cells. Infection and Immunity. 76: 2070-9. PMID 18285492 DOI: 10.1128/Iai.01246-07  0.373
2007 Brandler S, Lucas-Hourani M, Moris A, Frenkiel MP, Combredet C, Février M, Bedouelle H, Schwartz O, Desprès P, Tangy F. Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus. Plos Neglected Tropical Diseases. 1: e96. PMID 18160988 DOI: 10.1371/Journal.Pntd.0000096  0.3
2007 Jouve M, Sol-Foulon N, Watson S, Schwartz O, Benaroch P. HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages. Cell Host & Microbe. 2: 85-95. PMID 18005723 DOI: 10.1016/J.Chom.2007.06.011  0.585
2007 Hoeffel G, Ripoche AC, Matheoud D, Nascimbeni M, Escriou N, Lebon P, Heshmati F, Guillet JG, Gannagé M, Caillat-Zucman S, Casartelli N, Schwartz O, De la Salle H, Hanau D, Hosmalin A, et al. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity. 27: 481-92. PMID 17869134 DOI: 10.1016/J.Immuni.2007.07.021  0.489
2007 Py B, Bouchet J, Jacquot G, Sol-Foulon N, Basmaciogullari S, Schwartz O, Biard-Piechaczyk M, Benichou S. The Siva protein is a novel intracellular ligand of the CD4 receptor that promotes HIV-1 envelope-induced apoptosis in T-lymphoid cells. Apoptosis : An International Journal On Programmed Cell Death. 12: 1879-92. PMID 17653867 DOI: 10.1007/S10495-007-0106-4  0.481
2007 Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, Sol-Foulon N, Le Roux K, Prevost MC, Fsihi H, Frenkiel MP, Blanchet F, Afonso PV, Ceccaldi PE, Ozden S, ... ... Schwartz O, et al. Characterization of reemerging chikungunya virus. Plos Pathogens. 3: e89. PMID 17604450 DOI: 10.1371/Journal.Ppat.0030089  0.5
2007 Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, de Monredon J, Roger JC, El Amrani M, Yvin JL, Jaffar MC, Frenkiel MP, Sourisseau M, Schwartz O, Butler-Browne G, et al. Human muscle satellite cells as targets of Chikungunya virus infection. Plos One. 2: e527. PMID 17565380 DOI: 10.1371/Journal.Pone.0000527  0.459
2007 Hodges A, Sharrocks K, Edelmann M, Baban D, Moris A, Schwartz O, Drakesmith H, Davies K, Kessler B, McMichael A, Simmons A. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nature Immunology. 8: 569-77. PMID 17496896 DOI: 10.1038/Ni1470  0.532
2007 Fackler OT, Alcover A, Schwartz O. Modulation of the immunological synapse: a key to HIV-1 pathogenesis? Nature Reviews. Immunology. 7: 310-7. PMID 17380160 DOI: 10.1038/Nri2041  0.525
2007 Di Bartolo V, Montagne B, Salek M, Jungwirth B, Carrette F, Fourtane J, Sol-Foulon N, Michel F, Schwartz O, Lehmann WD, Acuto O. A novel pathway down-modulating T cell activation involves HPK-1-dependent recruitment of 14-3-3 proteins on SLP-76. The Journal of Experimental Medicine. 204: 681-91. PMID 17353368 DOI: 10.1084/Jem.20062066  0.34
2007 Schwartz O. Langerhans cells lap up HIV-1. Nature Medicine. 13: 245-6. PMID 17342114 DOI: 10.1038/Nm0307-245  0.523
2007 Sol-Foulon N, Sourisseau M, Porrot F, Thoulouze MI, Trouillet C, Nobile C, Blanchet F, di Bartolo V, Noraz N, Taylor N, Alcover A, Hivroz C, Schwartz O. ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation. The Embo Journal. 26: 516-26. PMID 17215865 DOI: 10.1038/Sj.Emboj.7601509  0.563
2007 Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O. Inefficient human immunodeficiency virus replication in mobile lymphocytes. Journal of Virology. 81: 1000-12. PMID 17079292 DOI: 10.1128/Jvi.01629-06  0.594
2006 Muratori C, D'Aloja P, Superti F, Tinari A, Sol-Foulon N, Sparacio S, Bosch V, Schwartz O, Federico M. Generation and characterization of a stable cell population releasing fluorescent HIV-1-based Virus Like Particles in an inducible way. Bmc Biotechnology. 6: 52. PMID 17192195 DOI: 10.1186/1472-6750-6-52  0.524
2006 Thoulouze MI, Sol-Foulon N, Blanchet F, Dautry-Varsat A, Schwartz O, Alcover A. Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity. 24: 547-61. PMID 16713973 DOI: 10.1016/J.Immuni.2006.02.016  0.558
2006 Fackler OT, Moris A, Tibroni N, Giese SI, Glass B, Schwartz O, Kräusslich HG. Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology. 351: 322-39. PMID 16684552 DOI: 10.1016/J.Virol.2006.03.044  0.58
2006 Moris A, Pajot A, Blanchet F, Guivel-Benhassine F, Salcedo M, Schwartz O. Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood. 108: 1643-51. PMID 16675708 DOI: 10.1182/Blood-2006-02-006361  0.586
2006 Ceccaldi PE, Delebecque F, Prevost MC, Moris A, Abastado JP, Gessain A, Schwartz O, Ozden S. DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells. Journal of Virology. 80: 4771-80. PMID 16641270 DOI: 10.1128/Jvi.80.10.4771-4780.2006  0.539
2006 Rybner-Barnier C, Jacquemot C, Cuche C, Doré G, Majlessi L, Gabellec MM, Moris A, Schwartz O, Di Santo J, Cumano A, Leclerc C, Lazarini F. Processing of the bovine spongiform encephalopathy-specific prion protein by dendritic cells. Journal of Virology. 80: 4656-63. PMID 16641258 DOI: 10.1128/Jvi.80.10.4656-4663.2006  0.375
2006 Esnault C, Millet J, Schwartz O, Heidmann T. Dual inhibitory effects of APOBEC family proteins on retrotransposition of mammalian endogenous retroviruses. Nucleic Acids Research. 34: 1522-31. PMID 16537839 DOI: 10.1093/Nar/Gkl054  0.342
2006 Zhang P, Schwartz O, Pantelic M, Li G, Knazze Q, Nobile C, Radovich M, He J, Hong SC, Klena J, Chen T. DC-SIGN (CD209) recognition of Neisseria gonorrhoeae is circumvented by lipooligosaccharide variation. Journal of Leukocyte Biology. 79: 731-8. PMID 16461738 DOI: 10.1189/Jlb.0405184  0.349
2006 Delebecque F, Suspène R, Calattini S, Casartelli N, Saïb A, Froment A, Wain-Hobson S, Gessain A, Vartanian JP, Schwartz O. Restriction of foamy viruses by APOBEC cytidine deaminases. Journal of Virology. 80: 605-14. PMID 16378963 DOI: 10.1128/Jvi.80.2.605-614.2006  0.492
2005 Tailleux L, Pham-Thi N, Bergeron-Lafaurie A, Herrmann JL, Charles P, Schwartz O, Scheinmann P, Lagrange PH, de Blic J, Tazi A, Gicquel B, Neyrolles O. DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis. Plos Medicine. 2: e381. PMID 16279841 DOI: 10.1371/Journal.Pmed.0020381  0.333
2005 Mahieux R, Suspène R, Delebecque F, Henry M, Schwartz O, Wain-Hobson S, Vartanian JP. Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases. The Journal of General Virology. 86: 2489-94. PMID 16099907 DOI: 10.1099/Vir.0.80973-0  0.514
2005 Nobile C, Petit C, Moris A, Skrabal K, Abastado JP, Mammano F, Schwartz O. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. Journal of Virology. 79: 5386-99. PMID 15827153 DOI: 10.1128/Jvi.79.9.5386-5399.2005  0.604
2005 Klena J, Zhang P, Schwartz O, Hull S, Chen T. The core lipopolysaccharide of Escherichia coli is a ligand for the dendritic-cell-specific intercellular adhesion molecule nonintegrin CD209 receptor. Journal of Bacteriology. 187: 1710-5. PMID 15716442 DOI: 10.1128/Jb.187.5.1710-1715.2005  0.305
2005 Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, Hance AJ, Heidmann T, Schwartz O. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature. 433: 430-3. PMID 15674295 DOI: 10.1038/Nature03238  0.379
2004 Sol-Foulon N, Esnault C, Percherancier Y, Porrot F, Metais-Cunha P, Bachelerie F, Schwartz O. The effects of HIV-1 Nef on CD4 surface expression and viral infectivity in lymphoid cells are independent of rafts. The Journal of Biological Chemistry. 279: 31398-408. PMID 15133044 DOI: 10.1074/Jbc.M401621200  0.584
2004 Cardinaud S, Moris A, Février M, Rohrlich PS, Weiss L, Langlade-Demoyen P, Lemonnier FA, Schwartz O, Habel A. Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames. The Journal of Experimental Medicine. 199: 1053-63. PMID 15078897 DOI: 10.1084/Jem.20031869  0.538
2004 Schwartz O. Cell of the month. Dendritic cell sensing a lymphocyte. Nature Reviews. Molecular Cell Biology. 5: 175. PMID 15017973 DOI: 10.1038/Nrm1352  0.354
2004 Schwartz O. [HIV-1, a very Vif virus]. Mã©Decine Sciences : M/S. 20: 139-41. PMID 14997428 DOI: 10.1051/Medsci/2004202139  0.531
2004 Ploquin MJ, Diop OM, Sol-Foulon N, Mortara L, Faye A, Soares MA, Nerrienet E, Le Grand R, Van Kooyk Y, Amara A, Schwartz O, Barré-Sinoussi F, Müller-Trutwin MC. DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm. Journal of Virology. 78: 798-810. PMID 14694112 DOI: 10.1128/Jvi.78.2.798-810.2004  0.452
2004 Moris A, Nobile C, Buseyne F, Porrot F, Abastado JP, Schwartz O. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood. 103: 2648-54. PMID 14576049 DOI: 10.1182/Blood-2003-07-2532  0.508
2004 Schwartz O. A dendritic cell sensing a lymphocyte Nature Cell Biology. 6: 188. DOI: 10.1038/Ncb0304-188  0.352
2003 Violot S, Hong SS, Rakotobe D, Petit C, Gay B, Moreau K, Billaud G, Priet S, Sire J, Schwartz O, Mouscadet JF, Boulanger P. The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1. Journal of Virology. 77: 12507-22. PMID 14610174 DOI: 10.1128/Jvi.77.23.12507-12522.2003  0.553
2003 Navarro-Sanchez E, Altmeyer R, Amara A, Schwartz O, Fieschi F, Virelizier JL, Arenzana-Seisdedos F, Desprès P. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. Embo Reports. 4: 723-8. PMID 12783086 DOI: 10.1038/Sj.Embor.Embor866  0.475
2003 Nobile C, Moris A, Porrot F, Sol-Foulon N, Schwartz O. Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN. Journal of Virology. 77: 5313-23. PMID 12692233 DOI: 10.1128/Jvi.77.9.5313-5323.2003  0.529
2003 Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A, Staropoli I, Foung S, Amara A, Houles C, Fieschi F, Schwartz O, Virelizier JL, Arenzana-Seisdedos F, Altmeyer R. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. The Journal of Biological Chemistry. 278: 20358-66. PMID 12609975 DOI: 10.1074/Jbc.M301284200  0.339
2003 Tailleux L, Schwartz O, Herrmann JL, Pivert E, Jackson M, Amara A, Legres L, Dreher D, Nicod LP, Gluckman JC, Lagrange PH, Gicquel B, Neyrolles O. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. The Journal of Experimental Medicine. 197: 121-7. PMID 12515819 DOI: 10.1084/Jem.20021468  0.366
2002 Marsac D, Loirat D, Petit C, Schwartz O, Michel ML. Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles. Journal of Virology. 76: 7544-53. PMID 12097567 DOI: 10.1128/Jvi.76.15.7544-7553.2002  0.513
2002 Sol-Foulon N, Moris A, Nobile C, Boccaccio C, Engering A, Abastado JP, Heard JM, van Kooyk Y, Schwartz O. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity. 16: 145-55. PMID 11825573 DOI: 10.1016/S1074-7613(02)00260-1  0.676
2001 Maréchal V, Prevost MC, Petit C, Perret E, Heard JM, Schwartz O. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. Journal of Virology. 75: 11166-77. PMID 11602756 DOI: 10.1128/Jvi.75.22.11166-11177.2001  0.727
2001 Stumptner-Cuvelette P, Morchoisne S, Dugast M, Le Gall S, Raposo G, Schwartz O, Benaroch P. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proceedings of the National Academy of Sciences of the United States of America. 98: 12144-9. PMID 11593029 DOI: 10.1073/Pnas.221256498  0.458
2001 Desmaris N, Bosch A, Salaün C, Petit C, Prévost MC, Tordo N, Perrin P, Schwartz O, de Rocquigny H, Heard JM. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. Molecular Therapy : the Journal of the American Society of Gene Therapy. 4: 149-56. PMID 11482987 DOI: 10.1006/Mthe.2001.0431  0.61
2001 Petit C, Buseyne F, Boccaccio C, Abastado JP, Heard JM, Schwartz O. Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes. Virology. 286: 225-36. PMID 11448175 DOI: 10.1006/Viro.2001.0984  0.717
2001 Janvier K, Craig H, Le Gall S, Benarous R, Guatelli J, Schwartz O, Benichou S. Nef-induced CD4 downregulation: a diacidic sequence in human immunodeficiency virus type 1 Nef does not function as a protein sorting motif through direct binding to beta-COP. Journal of Virology. 75: 3971-6. PMID 11264386 DOI: 10.1128/Jvi.75.8.3971-3976.2001  0.444
2001 Buseyne F, Le Gall S, Boccaccio C, Abastado JP, Lifson JD, Arthur LO, Rivière Y, Heard JM, Schwartz O. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nature Medicine. 7: 344-9. PMID 11231634 DOI: 10.1038/85493  0.743
2000 Le Gall S, Buseyne F, Trocha A, Walker BD, Heard JM, Schwartz O. Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation. Journal of Virology. 74: 9256-66. PMID 10982373 DOI: 10.1128/Jvi.74.19.9256-9266.2000  0.59
2000 Petit C, Schwartz O, Mammano F. The karyophilic properties of human immunodeficiency virus type 1 integrase are not required for nuclear import of proviral DNA. Journal of Virology. 74: 7119-26. PMID 10888652 DOI: 10.1128/Jvi.74.15.7119-7126.2000  0.485
2000 Liu LX, Heveker N, Fackler OT, Arold S, Le Gall S, Janvier K, Peterlin BM, Dumas C, Schwartz O, Benichou S, Benarous R. Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions. Journal of Virology. 74: 5310-9. PMID 10799608 DOI: 10.1128/Jvi.74.11.5310-5319.2000  0.454
1999 Piguet V, Schwartz O, Le Gall S, Trono D. The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors. Immunological Reviews. 168: 51-63. PMID 10399064 DOI: 10.1111/J.1600-065X.1999.Tb01282.X  0.502
1999 Petit C, Schwartz O, Mammano F. Oligomerization within virions and subcellular localization of human immunodeficiency virus type 1 integrase. Journal of Virology. 73: 5079-88. PMID 10233971 DOI: 10.1128/Jvi.73.6.5079-5088.1999  0.569
1999 Maréchal V, Arenzana-Seisdedos F, Heard JM, Schwartz O. Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication. Journal of Virology. 73: 3608-15. PMID 10196252 DOI: 10.1128/Jvi.73.5.3608-3615.1999  0.724
1998 Le Gall S, Erdtmann L, Benichou S, Berlioz-Torrent C, Liu L, Benarous R, Heard JM, Schwartz O. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity. 8: 483-95. PMID 9586638 DOI: 10.1016/S1074-7613(00)80553-1  0.618
1998 Schwartz O, Maréchal V, Friguet B, Arenzana-Seisdedos F, Heard JM. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. Journal of Virology. 72: 3845-50. PMID 9557668 DOI: 10.1128/Jvi.72.5.3845-3850.1998  0.74
1998 Maréchal V, Clavel F, Heard JM, Schwartz O. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. Journal of Virology. 72: 2208-12. PMID 9499078 DOI: 10.1128/Jvi.72.3.2208-2212.1998  0.692
1997 Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, Arenzana-Seisdedos F. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. The Journal of Experimental Medicine. 186: 139-46. PMID 9207008 DOI: 10.1084/Jem.186.1.139  0.489
1997 Liu LX, Margottin F, Le Gall S, Schwartz O, Selig L, Benarous R, Benichou S. Binding of HIV-1 Nef to a novel thioesterase enzyme correlates with Nef-mediated CD4 down-regulation. The Journal of Biological Chemistry. 272: 13779-85. PMID 9153233 DOI: 10.1074/Jbc.272.21.13779  0.568
1997 Le Gall S, Prevost MC, Heard JM, Schwartz O. Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity. Virology. 229: 295-301. PMID 9123874 DOI: 10.1006/Viro.1996.8417  0.711
1997 Le Gall S, Heard JM, Schwartz O. Analysis of Nef-induced MHC-I endocytosis. Research in Virology. 148: 43-7. PMID 9017833 DOI: 10.1016/S0923-2516(97)81912-7  0.502
1996 Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 382: 833-5. PMID 8752281 DOI: 10.1038/382833A0  0.72
1996 Champseix C, Maréchal V, Khazaal I, Schwartz O, Fournier S, Schlegel N, Dranoff G, Danos O, Blot P, Vilmer E, Heard JM, Péault B, Lehn P. A cell surface marker gene transferred with a retroviral vector into CD34+ cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus. Blood. 88: 107-13. PMID 8704164  0.582
1996 Schwartz O, Maréchal V, Le Gall S, Lemonnier F, Heard JM. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Medicine. 2: 338-42. PMID 8612235 DOI: 10.1038/nm0396-338  0.702
1995 Schwartz O, Dautry-Varsat A, Goud B, Maréchal V, Subtil A, Heard JM, Danos O. Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. Journal of Virology. 69: 528-33. PMID 7983750 DOI: 10.1128/Jvi.69.1.528-533.1995  0.636
1995 Schwartz O, Maréchal V, Danos O, Heard JM. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. Journal of Virology. 69: 4053-9. PMID 7539505 DOI: 10.1128/Jvi.69.7.4053-4059.1995  0.703
1994 Schwartz O, Alizon M, Heard JM, Danos O. Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology. 198: 360-5. PMID 7903129 DOI: 10.1006/Viro.1994.1042  0.664
1993 Schwartz O, Rivière Y, Heard JM, Danos O. Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef. Journal of Virology. 67: 3274-80. PMID 8497051 DOI: 10.1128/Jvi.67.6.3274-3280.1993  0.712
1993 Robertson MN, Buseyne F, Schwartz O, Rivière Y. Efficient antigen presentation to cytotoxic T lymphocytes by cells transduced with a retroviral vector expressing the HIV-1 Nef protein. Aids Research and Human Retroviruses. 9: 1217-23. PMID 7511396 DOI: 10.1089/Aid.1993.9.1217  0.56
1992 Schwartz O, Arenzana-Seisdedos F, Heard JM, Danos O. Activation pathways and human immunodeficiency virus type 1 replication are not altered in CD4+ T cells expressing the nef protein. Aids Research and Human Retroviruses. 8: 545-51. PMID 1355346 DOI: 10.1089/Aid.1992.8.545  0.667
1990 Schwartz O, Virelizier JL, Montagnier L, Hazan U. A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. Gene. 88: 197-205. PMID 2189784 DOI: 10.1016/0378-1119(90)90032-M  0.523
1988 Schwartz O, Henin Y, Marechal V, Montagnier L. A rapid and simple colorimetric test for the study of anti-HIV agents. Aids Research and Human Retroviruses. 4: 441-8. PMID 2464361 DOI: 10.1089/Aid.1988.4.441  0.435
Show low-probability matches.